**Core Concept**
The question tests the understanding of **chirality** in pharmacology, specifically focusing on drugs that are marketed as **racemic mixtures**. A racemic mixture contains equal amounts of two enantiomers, which are molecules that are mirror images of each other. This concept is crucial in pharmacology because the **pharmacological effects** of drugs can significantly differ between their enantiomers.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general principle. Drugs marketed as racemic mixtures contain both enantiomers of a compound. However, some drugs are marketed as a single enantiomer, which can offer **improved efficacy** or **reduced side effects** compared to the racemic mixture. This decision is based on the **pharmacokinetic** and **pharmacodynamic properties** of each enantiomer.

**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific drug, it's hard to provide a detailed explanation, but typically, a drug marketed as a single enantiomer would be the correct answer.
**Option B:** Similarly, without the drug name, we can't discuss its specific marketing form.
**Option C:** This option would be incorrect if it's a drug known to be marketed as a racemic mixture.
**Option D:** Same as the other options, lacking the drug name makes it impossible to provide a detailed explanation.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the **pharmacological activity** of a drug can reside primarily in one enantiomer, and separating and marketing the active enantiomer can reduce side effects and improve efficacy.

**Correct Answer:** Not provided in the query.